Sergio Traversa's Net Worth
$2.2 Million
Who is Sergio Traversa?
Sergio Traversa has an estimated net worth of $2.2 Million. This is based on reported shares across multiple companies, which include RELMADA THERAPEUTICS, INC., and Actinium Pharmaceuticals, Inc..
SEC CIK
Sergio Traversa's CIK is 0001565832
Past Insider Trading and Trends
2015 was Sergio Traversa's most active year for acquiring shares with 12 total transactions. Sergio Traversa's most active month to acquire stocks was the month of November. 2021 was Sergio Traversa's most active year for disposing of shares, totalling 27 transactions. Sergio Traversa's most active month to dispose stocks was the month of January. 2019 saw Sergio Traversa paying a total of $18,954,500.00 for 2,050,000 shares, this is the most they've acquired in one year. In 2021 Sergio Traversa cashed out on 113,281 shares for a total of $1,725,624.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RELMADA THERAPEUTICS, INC. (RLMD) Snapshot price: $4.55
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +69.43% | 100K |
$3.87 | $386,737.56 | 244.02K |
Jan 29 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +62.24% | 55.25K |
$2.10 | $115,804.00 | 144.02K |
Dec 8
| |||
Form 4
|
—
|
0
|
$17.40 | -$83,305.24 | 88.77K |
Jun 30 - Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
$19.37 | -$322,444.93 | 281.49K |
Scheduled
|
Mar 9 - Mar 10
| ||
Form 4
|
—
|
0
|
$18.74 | -$309,992.06 | 88.77K |
Scheduled
|
Feb 24
| ||
Form 4
|
—
|
0
|
$19.34 | -$46,553.39 | 88.77K |
Scheduled
|
Feb 11
| ||
Form 4
|
—
|
0
|
$19.21 | -$357,777.22 | 88.77K |
Scheduled
|
Feb 8 - Feb 10
| ||
Form 4
| +17.59% | 13.28K |
$3.24 | $43,030.44 | 88.77K |
Feb 2
| |||
Form 4
|
—
|
0
|
$19.14 | -$104,348.90 | 177.75K |
Scheduled
|
Feb 2 - Feb 3
| ||
Form 4
|
—
|
0
|
$17.82 | -$291,514.41 | 75.49K |
Scheduled
|
Jan 27
| ||
Form 4
|
—
|
0
|
$19.34 | -$130,993.14 | 75.49K |
Scheduled
|
Jan 22 - Jan 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +154.73% | 45.86K |
$21.14 | $12.39 | 75.49K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 4
| +5.92% | 18.97K |
$3.05 | $57,792.11 | 339.32K |
Dec 15
| |||
Form 4
| +0.01% | 30 |
$2.97 | $89.10 | 320.35K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $5.56
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
∞
| 3K |
$2.02 | $6,060.00 | 3K |
Apr 14 - Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
∞
| 10K |
$3.60 | $36,000.00 |
0
|
Aug 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||